institutionsInstitution

Docrates Cancer Center

Docrates is a private cancer clinic in Helsinki, founded in 2009, that serves international patients with diagnostics, treatment and follow-up under one personal care team.

Docrates Cancer Center in Helsinki provides high-quality individual diagnostics and the latest treatments to Finnish and international patients under a personal care team model, and is bookable internationally according to Future of Cancer Care Today.

Location

Helsinki, FI

Type

cancer center

Website

docrates.mehilainen.fi/en/

Newsweek 2026 oncology rank

Not in top 300 listing used

OnCo score

#583 · 4 points (0 Newsweek + 0 NCI + 4 from 2 linked objects) · ranking

Research output

From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-17.

Matched to Docrates Cancer Center, including child institutions. 17 works · 85 citations · 76% open access · 18% clinical trials · 0% reviews.

Oncology works per year

52022

42023

32024

22025

32026

Most works

Most cited

Work	Journal	Year	Citations
Health-Related Quality of Life in Metastatic Colorectal Cancer Patients Treated with Curative Resection and/or Local Ablative Therapy or Systemic Therapy in the Finnish RAXO-Study 10.3390/cancers14071713 · open access	Cancers	2022	22
Resectability, conversion, metastasectomy and outcome according to RAS and BRAF status for metastatic colorectal cancer in the prospective RAXO study 10.1038/s41416-022-01858-8 · open access	British Journal of Cancer	2022	18
Resectability, Resections, Survival Outcomes, and Quality of Life in Older Adult Patients with Metastatic Colorectal Cancer (the RAXO-Study) 10.3390/jcm12103541 · open access	Journal of Clinical Medicine	2023	10
Efficacy and safety of PARP inhibitors in the treatment of prostatic cancer: a systematic review and network meta-analysis 10.21037/cco-24-82 · open access	Chinese Clinical Oncology	2024	9
Atypical (non‐V600E) BRAF mutations in metastatic colorectal cancer in population and real‐world cohorts 10.1002/ijc.34733 · open access	International Journal of Cancer	2023	9
Resectability and resection rates of colorectal liver metastases according to RAS and BRAF mutational status: prospective study 10.1093/bjs/znac424 · open access	British journal of surgery	2022	6
Is Exercise During Androgen Deprivation Therapy Effective and Safe? A Randomized Controlled Trial 10.1111/sms.70084 · open access	Scandinavian Journal of Medicine and Science in Sports	2025	5
607P Impact of primary tumour sidedness (PTS) on demographics, resectability, and outcome after metastasectomy +/- local ablative therapy (LAT), or systemic therapy in metastatic colorectal cancer patients (a RAXO substudy) 10.1016/j.annonc.2023.09.1798 · open access	Annals of Oncology	2023	2
Exploratory biomarker analysis of RAS/BRAF somatic mutations and gene expression signatures for predicting treatment effects of aflibercept in the velour trial 10.1038/s41698-025-01253-5 · open access	npj Precision Oncology	2026	1
Impact of Primary Tumor Location on Demographics, Resectability, Outcomes, and Quality of Life in Finnish Metastatic Colorectal Cancer Patients (Subgroup Analysis of the RAXO Study) 10.3390/cancers16051052 · open access	Cancers	2024	1
749 Early phase oncology experience on the use of an oncolytic adenovirus encoding for TNFa and IL-2 for the treatment of solid tumors – Interim results conference abstract · 10.1136/jitc-2023-sitc2023.0749 · open access	Regular and Young Investigator Award Abstracts	2023	1
Abstract 1624: Immune cell killing assay for measuring the effects of immunomodulating agents in lung cancer cells in vitro conference abstract · 10.1158/1538-7445.am2022-1624	Cancer Research	2022	1
First systematic mapping of non-target [68Ga]Ga-DOTANOC uptake across anatomical sites and etiologies 10.1093/bjr/tqag181	British Journal of Radiology	2026	0
Evaluation of Radiotherapy Dose in Secondary Breast Angiosarcoma: Implications for Pathogenesis 10.21873/anticanres.18046	Anticancer Research	2026	0
Follow-Up of Cancer Patients Receiving Anti-PD-(L)1 Therapy Using an Electronic Patient-Reported Outcomes Tool (KISS): Prospective Feasibility Cohort Study · open access	UTUPub (University of Turku)	2025	0

Connected

Similar pages

Company
Private Health Management
Shares Future of Cancer Care Today (FCCT), Multidisciplinary tumour boards and the tag fcct-directory.
Company
Private Medical
Shares Future of Cancer Care Today (FCCT), Multidisciplinary tumour boards and the tag fcct-directory.
Company
Pathfinder Oncology
Shares Future of Cancer Care Today (FCCT), Multidisciplinary tumour boards and the tag fcct-directory.
Company
OncoDNA
Shares Future of Cancer Care Today (FCCT) and the tag fcct-directory.
Company
Protean BioDiagnostics
Shares Future of Cancer Care Today (FCCT) and the tag fcct-directory.
Company
Invoke Bio
Shares Future of Cancer Care Today (FCCT) and the tag fcct-directory.
Company
Jaime Leandro Foundation
Shares Future of Cancer Care Today (FCCT) and the tag fcct-directory.
Company
StoreMyTumor
Shares Future of Cancer Care Today (FCCT) and the tag fcct-directory.

technologies

Multidisciplinary tumour boards

companies

Future of Cancer Care Today (FCCT)